CIK: 0001757283 · Show all filings
Period: Q4 2025
Filing Date: Feb 17, 2026
Total Value ($000): $176,607 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KMTS | KESTRA MED TECHNOLOGIES LTD | 2,540,106 | $67,364 | 38.1% | $25.75 | 0.0% | SHS | G52441105 |
| MLYS | MINERALYS THERAPEUTICS INC | 1,591,917 | $57,771 | 32.7% | $40.10 | 0.0% | COM | 603170101 |
| EVMN | EVOMMUNE INC | 1,897,362 | $32,483 | 18.4% | $18.78 | 0.0% | COM SHS | 30054Y107 |
| ABVX | ABIVAX SA | 78,125 | $10,536 | 6.0% | $134.85 | — | SPONSORED ADS | 00370M103 |
| IVA | INVENTIVA SA | 1,818,181 | $8,455 | 4.8% | $4.65 | — | ADS | 46124U107 |